University of Minnesota Medical School researchers found that spleen-driven T cell exhaustion can promote organ transplant ...

The startup is developing a medicine that can very specifically degrade cancerous forms of EGFR, the target of several ...

Selected 1500 mg of ficerafusp alfa as the optimal dose for the treatment of 1L HPV-negative R/M HNSCC in Phase 3 FORTIFI-HN01 pivotal ...

New research from the University of Minnesota Medical School offers a new view of how the immune system responds to organ ...

Rybrevant Faspro, the new subcutaneous version of amivantamab, was approved for patients with a specific form of lung cancer driven by changes in the EGFR gene ...

Dual-payload ADCs are gaining traction, offering opportunities to overcome the tumour heterogeneity and resistance challenges ...

New research from the University of Minnesota Medical School offers a new view of how the immune system responds to organ ...

New research from the University of Minnesota Medical School offers a new view of how the immune system responds to organ transplants. The findings, published today in Science AdvancesExternal link ...

New research from the University of Minnesota Medical School offers a new view of how the immune system responds to ...

Phase 2 BESTOW trial data evaluating tegoprubart in kidney transplantation showed favorable efficacy, safety and tolerability, supporting ...

Phase 2 BESTOW trial data evaluating tegoprubart in kidney transplantation showed favorable efficacy, safety and tolerability, supporting advancement into Phase 3 development Reported positive prelimi ...

Harmony Biosciences Holdings, Inc. today announced strong preliminary, unaudited net product revenue for Q4 and full year ...